TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MDWD

Mediwound Ltd

Healthcare · Biotechnology

13.80$ +1.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Mediwound Ltd (MDWD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 72 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MDWD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
40 36 32 27 49 44 41 37 35 35 35 50 44 41 38 35 35 31 30 26 23 20 26 21 29 50 69 64 67 66 62 57 75 73 69 67 94 86 80 72
38 34 29 25 46 42 38 34 32 33 30 45 39 36 33 30 30 26 25 22 19 15 22 17 24 46 63 58 53 50 44 37 54 52 47 43 70 60 52 43
5.2 29 4.2 2.8 25 36 10.0 5.7 4.9 6.7 7.1 25 7.7 7.2 8.0 13 11 17 18 17 14 11 17 7.7 18 34 51 19 9.3 12 36 3.8 46 9.2 38 1.1 59 4.8 45 4.3
34 30 25 21 41 36 33 27 26 24 21 39 33 29 27 24 25 21 18 17 14 11 17 10 18 34 57 51 46 42 36 29 46 9.2 38 32 59 53 45 35
2.6 2.7 3.3 3.1 4.2 3.4 3.3 5.2 4.7 7.3 6.7 4.6 5.2 4.6 3.5 3.5 3.5 2.8 5.6 2.9 3.6 2.3 3.2 4.4 5.0 9.7 3.5 3.8 4.1 4.4 5.3 4.9 5.3 5.9 5.2 6.8 6.0 2.4 2.7 3.5
1.1 0.8 1.0 1.1 1.6 1.9 2.0 1.9 1.7 1.7 1.5 1.5 1.4 1.6 2.0 1.9 1.8 1.4 1.5 1.4 1.3 1.2 1.9 2.0 1.9 2.0 2.5 3.1 3.7 2.8 3.3 3.2 3.0 2.7 3.6 3.8 4.4 4.1 4.8 4.1
1.4 1.3 1.4 1.4 1.8 1.9 1.9 2.1 2.0 2.0 4.6 4.5 4.4 4.5 4.5 4.4 4.6 4.5 4.4 4.4 4.2 4.0 3.9 3.8 3.7 3.6 4.9 – – – – – – – – – – – – –
0.8 0.8 0.7 0.7 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 –
31 28 28 28 37 35 36 36 37 26 30 32 26 25 25 24 27 24 18 24 16 24 24 23 18 39 35 22 34 35 39 31 40 42 38 38 44 43 39 36
5.0 5.4 5.1 4.2 13 5.4 6.3 5.7 5.9 4.9 7.5 11 11 10 11 9.8 12 8.3 10 9.7 10.0 11 11 10 9.0 12 9.3 8.3 8.4 11 22 23 26 27 22 29 26 26 22 19
– 2.1 – – – 2.2 – – – – 2.0 – 5.5 5.5 – – 3.1 1.9 1.9 – 1.9 3.1 2.5 2.5 2.5 0.5 – – – 1.5 1.5 1.5 – – – 0.8 1.1 0.6 0.9 0.9
1.0 1.5 2.7 2.1 3.3 3.3 3.4 3.3 3.6 2.7 3.0 4.1 2.9 4.1 3.4 2.4 3.2 3.0 3.3 4.1 3.7 4.7 5.6 4.9 3.6 5.7 3.4 3.5 3.7 4.2 4.2 2.7 3.1 4.1 5.0 5.9 8.5 3.6 7.4 7.6
7.6 6.8 7.0 7.2 7.4 7.4 7.6 7.8 7.9 – 2.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
8.9 7.8 3.8 -0.4 12 9.6 5.0 1.0 -1.8 9.0 5.1 18 18 15 13 10 8.6 7.3 4.8 2.1 -0.8 -4.6 1.9 -2.2 1.7 11 33 35 33 32 23 18 34 31 31 20 50 44 41 36
-105 -107 -112 -116 -127 -129 -134 -138 -141 -131 -135 -122 -122 -126 -128 -131 -133 -135 -138 -141 -144 -149 -152 -156 -161 -168 – -171 – -175 -191 -191 – -205 – -219 – -229 – -239
3.1 3.1 3.1 3.1 3.2 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 4.1 4.7 4.8 6.3 8.4 9.2 9.2 9.2 9.2 9.3 11 11 11 11 11 13 13 13

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?